BioSig Technologies (NSDQ:BSGM) announced today that it closed a registered direct offering of common stock worth $17.5 million. The Westport, Conn.-based company and its majority-owned subsidiary, ViralClear Pharmaceuticals, sold nearly 2.2 million shares of common stock at $8 per share, closing the offering on June 26. Proceeds from the offering reached $17.5 million before deducting placement […]
Biosign Technologies Inc.
BioSig Technologies (NSDQ:BSGM) announced today that it successfully completed 100 patient cases with its Pure EP electrocardiographic system. The Pure EP is designed to acquire, digitize, measure, display and store electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures. Westport, Conn.–based BioSig initiated its first clinical trial in November 2019 and is currently enrolling at the Texas […]
BioSig Technologies (NSDQ:BSGM) said yesterday that it signed a new licensing agreement with Mayo Clinic to further its Pure EP system, less than two months after the Mayo Clinic invested $1 million in BioSig’s first product. Westport, Conn.-based BioSig and the Rochester, Minn.-based clinic inked a 10-year strategic partnership agreement for the Pure EP system’s […]
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
Diamyd Medical AB (OTC:DMYDY) and its CEO parted ways after the chief executive had a falling out with the company’s board.
Elisabeth Lindner left her position with the company "due to disagreement with the Board concerning certain important matters," the company said in prepared remarks.